My Cart [ 0 ]
Home > Cell Biology > Stable Cell Lines > Xgeva / Prolia Biosimilar Stable Cell Line

Xgeva / Prolia Biosimilar Stable Cell Line

Denosumab, Anti-RANKL Human Monoclonal Antibody
Catalog No. Product Name Size List Price (US$) Quantity
C004 Xgeva / Prolia Biosimilar Stable Cell Line 1 package Request
Description

Denosumab (trade name Xgeva, Prolia, Amgen), a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone.

C004: Xgeva / Prolia Biosimilar Stable Cell Line (CHO)

The yield of Xgeva / Prolia biosimilar from the CHO stable cell line was above 9.0 g/L in a 15 liter manufacturing.

The Xgeva / Prolia biosimilar stable cell line alone can be transfered alone or together with the technology of process development and/or antibody purification.

Related Links

Super savings and terrific tips sent to your email inbox:

See our Privacy Policy